RCEL
AVITA Medical Inc
Price:  
8.17 
USD
Volume:  
130,481.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AVITA EV/EBITDA

-457.7%
Upside

As of 2024-05-21, the EV/EBITDA ratio of AVITA Medical Inc (RCEL) is -5.70. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AVITA's latest enterprise value is 235.14 mil USD. AVITA's TTM EBITDA according to its financial statements is -41.28 mil USD. Dividing these 2 quantities gives us the above AVITA EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 11.1x - 20.0x 15.4x
Forward P/E multiples 16.8x - 21.9x 19.9x
Fair Price (27.89) - (33.01) (29.22)
Upside -441.3% - -504.0% -457.7%
8.17 USD
Stock Price
(29.22) USD
Fair Price

AVITA EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-05-20 -5.70
2024-05-17 -5.76
2024-05-16 -5.54
2024-05-15 -5.72
2024-05-14 -6.04
2024-05-13 -5.81
2024-05-10 -5.75
2024-05-09 -6.03
2024-05-08 -6.19
2024-05-07 -6.45
2024-05-06 -6.15
2024-05-03 -6.06
2024-05-02 -6.04
2024-05-01 -6.00
2024-04-30 -5.84
2024-04-29 -6.04
2024-04-26 -5.92
2024-04-25 -5.78
2024-04-24 -5.95
2024-04-23 -6.20
2024-04-22 -5.93
2024-04-19 -5.99
2024-04-18 -6.13
2024-04-17 -6.45
2024-04-16 -6.65
2024-04-15 -6.50
2024-04-12 -6.77
2024-04-11 -7.06
2024-04-10 -9.62
2024-04-09 -9.95
2024-04-08 -10.05
2024-04-05 -10.21
2024-04-04 -10.04
2024-04-03 -10.05
2024-04-02 -10.10
2024-04-01 -10.31
2024-03-28 -10.61
2024-03-27 -10.90
2024-03-26 -10.58
2024-03-25 -10.51
2024-03-22 -10.40
2024-03-21 -10.67
2024-03-20 -10.68
2024-03-19 -10.62
2024-03-18 -10.48
2024-03-15 -10.86
2024-03-14 -11.00
2024-03-13 -11.27
2024-03-12 -11.22
2024-03-11 -10.87